Based on the measurements of operating efficiency obtained from National HealthCare's historical financial statements, National HealthCare may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At present, National HealthCare's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 1 B, whereas Total Assets are forecasted to decline to about 798.6 M. Key indicators impacting National HealthCare's financial strength include:
The essential information of the day-to-day investment outlook for National HealthCare includes many different criteria found on its balance sheet. An individual investor should monitor National HealthCare's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in National HealthCare.
Please note, the presentation of National HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, National HealthCare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of National HealthCare's management manipulating its earnings.
National HealthCare Stock Summary
National HealthCare competes with Ensign, US Physicalrapy, Cass Information, and Brookdale Senior. National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and a behavioral health hospital. National HealthCare Corporation was founded in 1971 and is based in Murfreesboro, Tennessee. National Healthcare operates under Medical Care Facilities classification in the United States and is traded on AMEX Exchange. It employs 12965 people.
Comparative valuation techniques use various fundamental indicators to help in determining National HealthCare's current stock value. Our valuation model uses many indicators to compare National HealthCare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across National HealthCare competition to find correlations between indicators driving National HealthCare's intrinsic value. More Info.
National HealthCare is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for National HealthCare is roughly 4.60 . At present, National HealthCare's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the National HealthCare's earnings, one of the primary drivers of an investment's value.
National HealthCare Systematic Risk
National HealthCare's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. National HealthCare volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on National HealthCare correlated with the market. If Beta is less than 0 National HealthCare generally moves in the opposite direction as compared to the market. If National HealthCare Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one National HealthCare is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of National HealthCare is generally in the same direction as the market. If Beta > 1 National HealthCare moves generally in the same direction as, but more than the movement of the benchmark.
National HealthCare Thematic Clasifications
National HealthCare is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in National HealthCare Stock are looking for potential investment opportunities by analyzing not only static indicators but also various National HealthCare's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of National HealthCare growth as a starting point in their analysis.
Price Earnings To Growth Ratio
0.43
At present, National HealthCare's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.
National HealthCare March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of National HealthCare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of National HealthCare. We use our internally-developed statistical techniques to arrive at the intrinsic value of National HealthCare based on widely used predictive technical indicators. In general, we focus on analyzing National Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build National HealthCare's daily price indicators and compare them against related drivers.
When running National HealthCare's price analysis, check to measure National HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National HealthCare is operating at the current time. Most of National HealthCare's value examination focuses on studying past and present price action to predict the probability of National HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National HealthCare's price. Additionally, you may evaluate how the addition of National HealthCare to your portfolios can decrease your overall portfolio volatility.
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance